BREAKING: Futures Jump On Megacap Tech Earnings Biotech giants Amgen (AMGN) and Alexion Pharmaceuticals (ALXN) reached an agreement Thursday in a patent battle over blockbuster rare-disease drug Soliris.Privacy Policy & Terms of Use Piper Sandler analyst Christopher Raymond remains bullish on Alexion's ability to protect its complement franchise.